VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 16:52:07 GMT 2025` Edited by `admin` on `Tue Apr 01 16:52:07 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	6G09NND37S
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FLT

Preferred Name

English

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1

Common Name

English

VEGFR1

Common Name

English

TYROSINE-PROTEIN KINASE RECEPTOR FLT

Common Name

English

FRT

Common Name

English

Code System Code Type Description

FDA UNII

6G09NND37S

Created by admin on Tue Apr 01 16:52:07 GMT 2025 , Edited by admin on Tue Apr 01 16:52:07 GMT 2025

PRIMARY

PHAROS

P17948

Created by admin on Tue Apr 01 16:52:07 GMT 2025 , Edited by admin on Tue Apr 01 16:52:07 GMT 2025

PRIMARY

UNIPROT

P17948

Created by admin on Tue Apr 01 16:52:07 GMT 2025 , Edited by admin on Tue Apr 01 16:52:07 GMT 2025

PRIMARY

From	To
1_27	1_81
1_132	1_181
1_226	1_285
1_428	1_509
1_551	1_610
1_656	1_705

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_74
N	1_138
N	1_170
N	1_225
N	1_297
N	1_376
N	1_391
N	1_448
N	1_521
N	1_571
N	1_594
N	1_599
N	1_640

Related Record Type Details


					Y7HJ4D4CRT

ODM-203

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					172030934T

TIVOZANIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					1C39JW444G

Cabozantinib

INHIBITOR -> TARGET

Amount:


					5DX9U76296

VATALANIB

INHIBITOR -> TARGET


					G6HRD2P839

Nintedanib

INHIBITOR -> TARGET

Amount:


					F40IRN5981

Ibcasertib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					NQU9IPY4K9

CEDIRANIB

INHIBITOR -> TARGET


					CEGM9YBNGD

Selpercatinib

INHIBITOR -> TARGET


					C9LVQ0YUXG

Axitinib

INHIBITOR -> TARGET


					B2K5L1L8S9

SURUFATINIB

INHIBITOR -> TARGET

Amount:


					PP449XA4BH

LUCITANIB

INHIBITOR -> TARGET

Amount:


					SP24YIT5YZ

CDX-301

AGONIST -> TARGET


					U1JK633AYI

MOTESANIB

INHIBITOR -> TARGET


					7Q29OXD98N

GLESATINIB

INHIBITOR -> TARGET


					VKU5X213Q7

BMS-690514

INHIBITOR -> TARGET


					5277GPA358

CENISERTIB

INHIBITOR -> TARGET

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					YP8G3I74EL

VOROLANIB

INHIBITOR -> TARGET


					GKF8S4C432

Catequentinib

INHIBITOR -> TARGET

Amount:


					T7H0B1R64U

ICRUCUMAB

INHIBITOR -> TARGET


					49DXG3M5ZW

FRUQUINTINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					86FCX28PTU

AGN-211745

INHIBITOR OF EXPRESSION->TARGET

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_888] [1_1027] [1_1143] [1_1187] [1_1216] [1_1283] [1_1301] [1_1307]				TYROSINE O-PHOSPHATE	2R86C98KDX

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL